Fidelity's stake is unchanged at 10.2%, signaling continued passive support. No activist intent or material change in ownership structure. Monitor for any future conversion to 13D or significant position changes.
Price Chart
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 5,520,152 shares of Eikon Therapeutics common stock as of September 30, 2026, representing 10.2% of outstanding shares. This is an increase from the prior filing (5,520,152 vs. 5,520,152 — same count, but the prior filing was as of June 30, 2026, so the stake is unchanged in absolute terms). The filing confirms Fidelity remains a passive, non-activist holder.
Key Financial Metrics
Key Facts
- FMR LLC (Fidelity) reports 5,520,152 shares of Eikon Therapeutics common stock as of September 30, 2026.
- Stake represents 10.2% of outstanding shares.
- Filing is an amendment to Schedule 13G, confirming passive investment intent.
- No change in share count from the prior filing (5,520,152 as of June 30, 2026).
- Fidelity entities include FIAM LLC (IA), Fidelity Management & Research Company LLC (IA), and Fidelity Management Trust Company (BK).
Financial Impact
No financial impact — passive stake disclosure with unchanged position.
Risk Factors
- Fidelity could reduce or exit the position in future quarters without prior notice.
- Passive 13G filers are not required to disclose trading activity between quarterly snapshots.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002331 |
| Document: 0000315066-26-002331-index-headers.html | 0000315066-26-002331 |
| Document: 0000315066-26-002331-index.html | 0000315066-26-002331 |
| Document: 0000315066-26-002331.txt | 0000315066-26-002331 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $7.48 | awaiting T+20 | — | $7.26 (−2.94%) |
Oct 26, 2026 today | Press Release | $7.48 | awaiting T+20 | — | $7.26 (−2.94%) |
Oct 23, 2026 2d ago | 8-K | $8.01 | awaiting T+20 | — | $7.26 (−9.36%) |
Oct 7, 2026 18d ago | SC 13G/A | $7.54 | awaiting T+20 | — | $7.26 (−3.71%) |
Oct 2, 2026 23d ago | SC 13G/A | $7.33 | awaiting T+20 | — | $7.26 (−0.95%) |
Sep 22, 2026 4w ago | Institutional Cluster | $8.98 $8.18 | ▼ −8.91% | ▼ −8.35% | $7.26 (−19.15%) |
Sep 8, 2026 6w ago | Insider Buy | $10.73 $7.54 | ▼ −29.73% | ▼ −31.67% | $7.26 (−32.34%) |
Sep 3, 2026 7w ago | Press Release | $10.96 $8.04 | ▼ −26.64% | ▼ −25.52% | $7.26 (−33.76%) |
Aug 13, 2026 10w ago | 8-K | $11.05 $9.36 | ▼ −15.29% | ▼ −13.30% | $7.26 (−34.30%) |
Jul 20, 2026 14w ago | Press Release | $9.65 $10.47 | ▲ +8.50% | ▲ +4.38% | $7.26 (−24.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers